|
|
Welcome to JobWatch--your one-stop resource for career and educational information! JobWatch is a job posting and career development site designed exclusively for clinical research professionals of all levels. Job seekers can easily post and update resumes, apply directly for open positions and sign up for e-mail alerts for new positions. It is also the perfect resource to learn more about upcoming conferences on clinical research-related topics or register for training and academic degree programs for careervdevelopment and advancement. Sign up for your free account and find your next opportunity right now! |
Job Search
Have questions or feedback?
E-mail jobwatch@centerwatch.com.
Career-Related News From Around The Industry
Headlines
PRA opens new facility in Wales, creates 100 graduate-level jobs
PRA, a global CRO, has officially opened its new facility in Swansea, Wales. The expansion is being supported with $1.9 million business finance from the Welsh government. The company is expanding its clinical informatics team in Swansea by establishing a new multi-lingual help desk, creating more positions in the data coordination, clinical programming and safety groups.[more]
BioDuro opens state-of-the-art discovery lab in Shanghai
BioDuro, a drug discovery services company owned by PPD, has opened a new state-of-the-art laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients an extensive range of customized drug discovery services in Asia Pacific.[more]
Industry Roundup: Comings and Goings
Chiltern appoints Niewel and Bull to senior positions |
Regenesis Biomedical names Scott Brooks as CEO |
|
|
Chiltern International, a global CRO based in the U.K., has appointed Dr. Manuela Niewel as medical director and Lisa Bull as director of strategic partnerships. Niewel is a medical oncologist with more than 20 years experience in clinical research in oncology and other major therapeutic areas. [more] |
The board of directors of Regenesis Biomedical, a privately held medical technology company focused on tissue regeneration, has unanimously elected Scott Brooks as the next chief executive officer and member of the board of directors, succeeding Virginia Rybski. Brooks will assume his new role immediately. [more] |






